X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15684) 15684
Newsletter (1398) 1398
Newspaper Article (1000) 1000
Book Chapter (180) 180
Magazine Article (179) 179
Trade Publication Article (28) 28
Dissertation (27) 27
Book Review (22) 22
Publication (11) 11
Conference Proceeding (10) 10
Book / eBook (8) 8
Web Resource (5) 5
Streaming Video (4) 4
Journal / eJournal (2) 2
Paper (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ace inhibitors (10445) 10445
humans (6845) 6845
male (4520) 4520
hypertension (4130) 4130
angiotensin (3679) 3679
female (3548) 3548
angiotensin-converting enzyme inhibitors - therapeutic use (3093) 3093
animals (2783) 2783
middle aged (2563) 2563
enzymes (2465) 2465
aged (2144) 2144
cardiac & cardiovascular systems (2006) 2006
pharmacology & pharmacy (1993) 1993
research (1935) 1935
angiotensin-converting enzyme inhibitors - pharmacology (1892) 1892
heart failure (1843) 1843
drug therapy (1821) 1821
ace-inhibitors (1716) 1716
hypertension - drug therapy (1618) 1618
adult (1601) 1601
risk factors (1568) 1568
rats (1487) 1487
mortality (1421) 1421
blood pressure (1398) 1398
ace inhibitor (1350) 1350
blood-pressure (1320) 1320
captopril (1290) 1290
ace (1217) 1217
angiotensin-converting enzyme (1206) 1206
blood pressure - drug effects (1203) 1203
health aspects (1200) 1200
care and treatment (1167) 1167
peripheral vascular disease (1111) 1111
analysis (1095) 1095
diabetes (1093) 1093
medicine, general & internal (1020) 1020
enalapril (993) 993
urology & nephrology (985) 985
renin-angiotensin system (939) 939
antihypertensive agents - therapeutic use (925) 925
treatment outcome (915) 915
angiotensin-converting enzyme inhibitors - adverse effects (909) 909
peptides (899) 899
ace-inhibition (876) 876
heart failure - drug therapy (835) 835
medicine & public health (818) 818
drug therapy, combination (812) 812
peptidyl-dipeptidase a - genetics (809) 809
renin-angiotensin system - drug effects (794) 794
cardiovascular disease (786) 786
physiological aspects (775) 775
myocardial-infarction (755) 755
medical research (746) 746
diuretics (738) 738
cardiology (734) 734
angiotensin-converting enzyme inhibitors - administration & dosage (725) 725
angiotensin-converting enzyme inhibitors (722) 722
bradykinin (705) 705
proteins (702) 702
antihypertensive drugs (692) 692
prevention (680) 680
peptidyl-dipeptidase a - metabolism (671) 671
risk (663) 663
angiotensin converting enzyme (654) 654
food science & technology (632) 632
disease (631) 631
dosage and administration (625) 625
hypertension - physiopathology (621) 621
therapy (610) 610
drugs (609) 609
heart (608) 608
genetic aspects (607) 607
proteinuria (606) 606
heart-failure (605) 605
aged, 80 and over (603) 603
ace-inhibitor (599) 599
system (599) 599
studies (594) 594
medicine, experimental (588) 588
kidney diseases (565) 565
internal medicine (563) 563
angiotensin ii (557) 557
biochemistry & molecular biology (557) 557
expression (546) 546
converting enzyme-inhibitors (531) 531
ace inhibition (529) 529
heart attacks (529) 529
cardiac patients (525) 525
renin (525) 525
time factors (521) 521
medicine (516) 516
double-blind method (512) 512
cardiovascular diseases (493) 493
dose-response relationship, drug (491) 491
peptidyl-dipeptidase a (488) 488
rodents (480) 480
angiotensin receptor antagonists (476) 476
left-ventricular dysfunction (475) 475
genotype (473) 473
usage (471) 471
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17718) 17718
German (377) 377
Russian (176) 176
Japanese (137) 137
French (82) 82
Spanish (69) 69
Czech (48) 48
Chinese (46) 46
Italian (44) 44
Portuguese (41) 41
Korean (32) 32
Polish (18) 18
Hungarian (14) 14
Slovak (13) 13
Croatian (4) 4
Dutch (4) 4
Hebrew (4) 4
Indonesian (4) 4
Serbian (4) 4
Turkish (4) 4
Slovenian (3) 3
Swedish (3) 3
Bosnian (2) 2
Arabic (1) 1
Danish (1) 1
Norwegian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European heart journal, ISSN 1522-9645, 2012, Volume 33, Issue 16, pp. 2088 - 2097
textabstractAimsRenin-Angiotensin-Aldosterone system (RAAS) inhibitors are well established for the reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive patients is uncertain... 
Hypertension | ARB | Mortality | ACE inhibitor | Meta-analysis | Humans | Middle Aged | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Cause of Death | Randomized Controlled Trials as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Female | Renin-Angiotensin System - drug effects | Aged | Hypertension - mortality | Clinical Research
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 18, pp. 1733 - 1745
...–enzyme (ACE) inhibitor–placebo, statin–placebo, ACE inhibitor–statin, or placebo–placebo. Neither medication resulted in a change in albumin excretion over 2 to 4 years. 
INTIMA-MEDIA THICKNESS | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | INTERVENTION TRIAL ADDIT | CONVERTING-ENZYME-INHIBITOR | GLUCOSE CONTROL | ALBUMIN EXCRETION | HIGH-RISK | MICROALBUMINURIA | YOUNG-PEOPLE | FOLLOW-UP | Albuminuria - etiology | Double-Blind Method | Area Under Curve | Humans | Male | Diabetes Mellitus, Type 1 - complications | Albuminuria - prevention & control | Creatinine - urine | Diabetes Mellitus, Type 1 - urine | Diabetes Mellitus, Type 1 - drug therapy | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Diabetes Mellitus, Type 1 - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipids - blood | Adolescent | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Drug Therapy, Combination | Child | Type 1 diabetes | Patient outcomes | Analysis | Outcome and process assessment (Health Care) | Dosage and administration | Drug therapy | ACE inhibitors | Statins | Creatinine | Puberty | Enzymes | C-reactive protein | Diabetes mellitus | Albumin | Triglycerides | Apolipoproteins | Cholesterol | Risk factors | Glomerular filtration rate | Apolipoprotein B | Peptidyl-dipeptidase A | Angiotensin | Teenagers | Diabetes | Cardiovascular diseases | Adolescents | Drug dosages | Age | Endocrinology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2020, Volume 382, Issue 17, pp. 1653 - 1659
.... The authors hypothesize that ACE2 may be beneficial rather than harmful during lung injury and suggest that RAAS-inhibitor withdrawal may be harmful in some high-risk... 
CONVERTING ENZYME 2 | MEDICINE, GENERAL & INTERNAL | OLMESARTAN | EXPERIMENTAL AUTOIMMUNE MYOCARDITIS | HEART-FAILURE | DOWN-REGULATION | ACE2 EXPRESSION | FUNCTIONAL RECEPTOR | SARS-CORONAVIRUS | HYPERTENSIVE PATIENTS | MODULATION | Pandemics | Down-Regulation | Humans | Angiotensin Receptor Antagonists - pharmacology | Hypertension - drug therapy | Renal Insufficiency, Chronic - complications | Betacoronavirus - metabolism | Renal Insufficiency, Chronic - drug therapy | Pneumonia, Viral - metabolism | Coronavirus Infections - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Pneumonia, Viral - complications | Peptidyl-Dipeptidase A - metabolism | Coronavirus Infections - complications | Hypertension - complications | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Angiotensin Receptor Antagonists - therapeutic use | Control | Physiological aspects | Development and progression | Research | Renin-angiotensin system | ACE inhibitors | Risk factors | Hypertension | Enzymes | Peptides | Risk groups | Cardiovascular disease | Coronaviruses | Aldosterone | Angiotensin-converting enzyme 2--ACE2 | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Proteins | Renin | Illnesses | Lungs | Peptidyl-dipeptidase A | Coronary vessels | Angiotensin | Physiology | Viral infections
Journal Article
Journal Article
Journal Article
Pediatric nephrology (Berlin, West), ISSN 1432-198X, 2018, Volume 34, Issue 9, pp. 1521 - 1532
Journal Article